Empiric intravenous fluid and electrolyte therapy in patients with Ebola virus disease.
The role of intravenous fluid and electrolyte replacement is increasingly recognised in the clinical management of Ebola virus disease. However, outbreaks typically occur in resource-limited settings where electrolyte measurement may be initially unavailable. Here we highlight potential strategies for empiric fluid and electrolyte therapy based on experience from Sierra Leone.
Liverpool School of Tropical Medicine, Liverpool, UK luke.hunt@doctors.org.uk.
Luke
L
Hunt
Department of Emergency Medicine, University of Alberta, Edmonton, Canada.
James S
JS
Lee
D004196:Disease Outbreaks; D004573:Electrolytes / Q000627:therapeutic use*; D005440:Fluid Therapy / Q000379:methods*; D019142:Hemorrhagic Fever, Ebola / Q000453:epidemiology / Q000628:therapy*; D006801:Humans; D012807:Sierra Leone / Q000453:epidemiology; D016896:Treatment Outcome
D004573:Electrolytes
Ebola; Ebola virus disease; clinical care; electrolyte replacement; intravenous fluid therapy